Profile | GDS2987 / GI_15451888-I |
Title | Comparison of Rho kinase inhibitor and atorvastatin effects on primary cell lines |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM214810 | HMVEC_vehicle_rep1 | 12 | 40 |
GSM215244 | HMVEC_vehicle_rep2 | 25.2 | 53 |
GSM215253 | HMVEC_vehicle_rep3 | 49.6 | 70 |
GSM215254 | HMVEC_atorvastatin_rep1 | 36.3 | 63 |
GSM215282 | HMVEC_atorvastatin_rep3 | 47.7 | 67 |
GSM215344 | HMVEC_atorvastatin_rep2 | 23.3 | 49 |
GSM215283 | HMVEC_atorvastatin_mevalonate_rep1 | 12.3 | 24 |
GSM215284 | HMVEC_atorvastatin_mevalonate_rep2 | 113.8 | 77 |
GSM215293 | HMVEC_atorvastatin_mevalonate_rep3 | 43 | 56 |
GSM215294 | HMVEC_SLx2119_rep1 | 74.2 | 74 |
GSM215295 | HMVEC_SLx2119_rep2 | 91.3 | 74 |
GSM215296 | HMVEC_SLx2119_rep3 | 54.6 | 64 |
GSM215297 | PASMC_vehicle_rep1 | ||
GSM215298 | PASMC_vehicle_rep2 | ||
GSM215310 | PASMC_vehicle_rep3 | 37.5 | 51 |
GSM215311 | PASMC_atorvastatin_rep1 | ||
GSM215312 | PASMC_atorvastatin_rep2 | ||
GSM215313 | PASMC_atorvastatin_rep3 | ||
GSM215324 | PASMC_atorvastatin_mevalonate_rep1 | ||
GSM215325 | PASMC_atorvastatin_mevalonate_rep2 | ||
GSM215326 | PASMC_atorvastatin_mevalonate_rep3 | ||
GSM215327 | PASMC_SLx2119_rep1 | ||
GSM215328 | PASMC_SLx2119_rep2 | ||
GSM215329 | PASMC_SLx2119_rep3 | ||
GSM215330 | Fibroblasts_vehicle_rep1 | 92 | 74 |
GSM215331 | Fibroblasts_vehicle_rep2 | 63.7 | 71 |
GSM215332 | Fibroblasts_vehicle_rep3 | 54.8 | 70 |
GSM215333 | Fibroblasts_atorvastatin_rep1 | 84.8 | 74 |
GSM215334 | Fibroblasts_atorvastatin_rep2 | 60.3 | 70 |
GSM215335 | Fibroblasts_atorvastatin_rep3 | 63 | 70 |
GSM215336 | Fibroblasts_atorvastatin_mevalonate_rep1 | 66 | 72 |
GSM215337 | Fibroblasts_atorvastatin_mevalonate_rep2 | 73.9 | 73 |
GSM215338 | Fibroblasts_atorvastatin_mevalonate_rep3 | 102.2 | 75 |
GSM215339 | Fibroblasts_SLx2119_rep1 | 93.2 | 74 |
GSM215340 | Fibroblasts_SLx2119_rep2 | 64.7 | 71 |
GSM215341 | Fibroblasts_SLx2119_rep3 | 71.8 | 72 |